SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maribel Forero-Castro, Cristina Robledo, Eva Lumbreras, Rocio Benito, Jesús M. Hernández-Sánchez, María Hernández-Sánchez, Juan L. García, Luis A. Corchete-Sánchez, Mar Tormo, Pere Barba, Javier Menárguez, Jordi Ribera, Carlos Grande, Lourdes Escoda, Carmen Olivier, Estrella Carrillo, Alfonso García de Coca, Josep-María Ribera, Jesús M. Hernández-Rivas, The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab, British Journal of Haematology, 2016, 172, 3
  2. 2
    Yazan Migdady, Mohammed Salhab, Nam H. Dang, Merry J. Markham, Adam J. Olszewski, Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis, Leukemia & Lymphoma, 2015, 1

    CrossRef

  3. 3
    A. Picard, C. Cardinne, Y. Denoux, I. Wagner, F. Chabolle, C.A. Bach, Extranodal lymphoma of the head and neck: A 67-case series, European Annals of Otorhinolaryngology, Head and Neck Diseases, 2015, 132, 2, 71

    CrossRef

  4. 4
    A. Picard, C. Cardinne, Y. Denoux, I. Wagner, F. Chabolle, C.-A. Bach, Lymphomes extra-ganglionnaires de la tête et du cou : à propos de 67cas, Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale, 2015, 132, 2, 69

    CrossRef

  5. 5
    Jorge J. Castillo, Adam J. Olszewski, Sandra Kanan, Kirsten Meid, Zachary R. Hunter, Steven P. Treon, Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database, British Journal of Haematology, 2015, 169, 1
  6. 6
    Adam J. Olszewski, Rajesh Shrestha, Nathaniel M. Cook, Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base, Cancer, 2015, 121, 19
  7. 7
    C. Jacobson, A. LaCasce, How I treat Burkitt lymphoma in adults, Blood, 2014, 124, 19, 2913

    CrossRef

  8. 8
    D. Hoelzer, J. Walewski, H. Dohner, A. Viardot, W. Hiddemann, K. Spiekermann, H. Serve, U. Duhrsen, A. Huttmann, E. Thiel, J. Dengler, M. Kneba, M. Schaich, I. G. H. Schmidt-Wolf, J. Beck, B. Hertenstein, A. Reichle, K. Domanska-Czyz, R. Fietkau, H.-A. Horst, H. Rieder, S. Schwartz, T. Burmeister, N. Gokbuget, Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial, Blood, 2014, 124, 26, 3870

    CrossRef

  9. 9
    Jorge J Castillo, Omar Nadeem, Improving the accuracy in prognosis for Burkitt lymphoma patients, Expert Review of Anticancer Therapy, 2014, 14, 2, 125

    CrossRef

  10. 10
    Adrienne Greenough, Sandeep S. Dave, New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing, Current Opinion in Hematology, 2014, 21, 4, 326

    CrossRef

  11. 11
    J. J. Castillo, A. J. Olszewski, A. M. Cronin, Z. R. Hunter, S. P. Treon, Survival trends in Waldenstrom macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database, Blood, 2014, 123, 25, 3999

    CrossRef

  12. You have free access to this content12
    Jorge J. Castillo, John L. Reagan, Kenneth D. Bishop, Emmanuel Apor, Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies, British Journal of Haematology, 2014, 165, 3